This site is intended for healthcare professionals
News

Phase III study of mRNA-1273 for prevention of symptomatic COVID-19 disease is expected to begin in July 2020 .- Moderna Inc.

Read time: 1 mins
Last updated:12th Jun 2020
Published:12th Jun 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com